drugset / Trial / NCT01809769
Autologous Adipose Tissue Derived Mesenchymal Stem Cells Therapy for Patients With Knee Osteoarthritis
RandomizedSingle-groupDouble-blindTreatment
Summary
Two injections in total and 3 ml autologous adipose-tissue-derived stem cells(haMSCs) for each injection; time-points for intervention: 1) initial injection; 2) 3 weeks following initial injection.
Timeline
- Start
- 2013-03
- Primary completion
- 2015-03
- Completion
- 2015-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adipose tissue derived mesenchymal stem cells | Cell therapy | 1e+07 cells | Other |
| Subject | Adipose tissue derived mesenchymal stem cells | Cell therapy | 2e+07 cells | Other |
| Subject | Adipose tissue derived mesenchymal stem cells | Cell therapy | 5e+07 cells | Other |